Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks Holdings, Inc. (DNA) Revenue
Annual & quarterly revenue history · segment & region breakdown
DNA · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsGinkgo Bioworks Holdings, Inc. trailing twelve-month (TTM) revenue is $0.14B, a decrease of 25.06% year-over-year from $0.17B in FY2025.
Revenue trend
2025 – 2019 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.17B | -$0.06B | -25.06% |
| 2024-12-31 | $0.23B | -$0.02B | -9.71% |
| 2023-12-31 | $0.25B | -$0.23B | -47.36% |
| 2022-12-31 | $0.48B | +$0.16B | +52.21% |
| 2021-12-31 | $0.31B | +$0.24B | +309.40% |
| 2020-12-31 | $0.08B | +$0.02B | +41.48% |
| 2019-12-31 | $0.05B | — | — |
Compare revenue vs peers
BiotechnologyCompare DNA revenue against listed peers. Click any row to open that company's revenue tab.
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Ginkgo Bioworks Holdings, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Ginkgo Bioworks Holdings, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Ginkgo Bioworks Holdings, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
DNA revenue · 4 questionsDNA's trailing twelve-month (TTM) revenue is $0.14B. That is a decrease of 25.06% year-over-year from $0.17B in FY2025.
▸ Source: FMP · Ginkgo Bioworks Holdings, Inc. SEC filings · GAAP · Ginkgo Bioworks Holdings, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026